Tectonic Therapeutic (TECX) Other Non-Current Assets (2017 - 2026)
Tectonic Therapeutic (TECX) reported Other Non-Current Assets of $663000.0 for Q1 2026, up 12.95% year-over-year from $587000.0 in Q1 2025, and up 36.7% quarter-over-quarter from $485000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Other Non-Current Assets data on file, last reported at $663000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $663000.0, up 12.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $663000.0 (up 12.95% YoY), and the FY2025 annual result was $485000.0, down 17.38% from the prior year.
- Other Non-Current Assets improved to $663000.0 in Q1 2026 per TECX's latest filing, from $485000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $669000.0 in Q4 2023 and troughed at $40000.0 in Q4 2022.
- A 5-year average of $506411.8 and a median of $587000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets surged 1572.5% in 2023, then sank 51.11% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $40000.0 in 2022, then soared by 1572.5% to $669000.0 in 2023, then decreased by 12.26% to $587000.0 in 2024, then declined by 17.38% to $485000.0 in 2025, then soared by 36.7% to $663000.0 in 2026.
- Business Quant data shows TECX's Other Non-Current Assets at $663000.0 in Q1 2026, $485000.0 in Q4 2025, and $597000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 663,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 663,000.00 |
| Dec 31, 2025 | 485,000.00 |
| Sep 30, 2025 | 597,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 587,000.00 |
| Dec 31, 2024 | 587,000.00 |
| Sep 30, 2024 | 587,000.00 |
| Jun 30, 2024 | 587,000.00 |
| Mar 31, 2024 | 587,000.00 |
| Dec 31, 2023 | 669,000.00 |
| Sep 30, 2023 | 587,000.00 |
| Jun 30, 2023 | 587,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 492,000.00 |
| Mar 31, 2022 | 492,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 492,000.00 |
| Jun 30, 2021 | 492,000.00 |